We therefore assessed the effect of EGFR inhibition in a mouse model of elastase-induced emphysema combined with RV infection, in which many features of human COPD exacerbation, including mucus hypersecretion, are recapitulated (27). Here, EGFR is linked to pulmonary emphysema.